|
|
Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence for Improved Patient Outcomes
STATEMENT OF NEED
Head and neck cancers represent a heterogeneous group of tumors that originate in the lip/oral cavity, hypopharynx, oropharynx, nasopharynx, and larynx. An estimated 66,470 new cases are diagnosed in the United States annually, and 15,050 people die of the disease (Siegel et al, 2022). Approximately 90% of cases are classified as head and neck squamous cell carcinoma (HNSCC). Treatment of HNSCC is complicated by numerous factors, including differing therapeutic strategies ... |
|
|
Cancer Treatment Related Cognitive Impairment - Connie Carson, PhD, CCC-SLP
Oncology professionals, nurses, neuropsychologists, and psychologists have established cancer treatment related cognitive impairment (CTRCI) as a common side-effect of cancer treatment, impacting as many as 75% of cancer survivors; yet, speech-language pathologists have been silent in establishing their role in the treatment of this phenomenon. This presentation will provide the necessary background for them to be able to do so. Clinical symptoms will be defined and therapeutic suggestions off... |
|